Evidence map›Paper›PMID 31713636›Full record

ArticleNucleic acids research2020

DisProt: intrinsic protein disorder annotation in 2020.

András Hatos, Borbála Hajdu-Soltész, Alexander M Monzon, Nicolas Palopoli, Lucía Álvarez, Burcu Aykac-Fas, Claudio Bassot, Guillermo I Benítez, Martina Bevilacqua, Anastasia Chasapi and 54 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. IsoProDB: an integrated map of human protein isoforms for accelerated research.Database : the journal of biological databases and curation · 2026
    Article
  6. Article
  7. Article
  8. Comparative assessment of binding residue predictions in intrinsically disordered regions.Protein science : a publication of the Protein Society · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Multitask Learning-Based Approaches for Protein Function Prediction.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  16. Prediction of Disordered Linkers Using APOD.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  17. Article
  18. Article
  19. Evaluation of predictions of disordered binding regions in the CAID2 experiment.Computational and structural biotechnology journal · 2025
    Review
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

64 authors.

András HatosDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.
Borbála Hajdu-SoltészMTA-ELTE Lendület Bioinformatics Research Group, Department of Biochemistry, Eötvös Loránd University, Budapest 1117, Hungary.
Alexander M MonzonDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.
Nicolas PalopoliDepartamento de Ciencia y Tecnología, Universidad Nacional de Quilmes - CONICET, Bernal, Buenos Aires B1876BXD, Argentina.
Lucía ÁlvarezConsejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biotecnológicas IIBIO, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Burcu Aykac-FasComputational Biology Laboratory, Danish Cancer Society Research Center, Copenhagen DK-2100, Denmark.
Claudio BassotDepartment of Biochemistry and Biophysics and Science for Life Laboratory, Stockholm University, Box 1031, Solna 17121, Sweden.
Guillermo I BenítezDepartamento de Ciencia y Tecnología, Universidad Nacional de Quilmes - CONICET, Bernal, Buenos Aires B1876BXD, Argentina.
Martina BevilacquaDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.
Anastasia ChasapiBiological Computation & Process Laboratory, Chemical Process & Energy Resources Institute, Centre for Research & Technology Hellas, Thessalonica GR-57500, Greece.
Lucia ChemesConsejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biotecnológicas IIBIO, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Norman E DaveyDivision of Cancer Biology, The Institute of Cancer Research, Chelsea, London SW3 6BJ, UK.
Radoslav DavidovićLaboratory for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences Vinca, University of Belgrade, Belgrade 11001, Serbia.
A Keith DunkerCenter for Computational Biology and Bioinformatics, Indiana University School of Medicine, IN 46202, USA.
Arne ElofssonDepartment of Biochemistry and Biophysics and Science for Life Laboratory, Stockholm University, Box 1031, Solna 17121, Sweden.
Julien GobeillSwiss Institute of Bioinformatics and HES-SO \ HEG, Geneva 1200, Switzerland.
Nicolás S González FoutelConsejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Investigaciones Biotecnológicas IIBIO, Universidad Nacional de San Martín, San Martín, Buenos Aires, Argentina.
Govindarajan SudhaDepartment of Biochemistry and Biophysics and Science for Life Laboratory, Stockholm University, Box 1031, Solna 17121, Sweden.
Mainak GuharoyStructural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels 1050, Belgium.
Tamas HorvathInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest H-1117, Hungary.
Valentin IglesiasDepartament de Bioquímica i Biologia Molecular and Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Bellaterra 08193, Spain.
Andrey V KajavaCentre de Recherche en Biologie cellulaire de Montpellier (CRBM), UMR 5237 CNRS, Université Montpellier, Montpellier 34293, France.
Orsolya P KovacsInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest H-1117, Hungary.
John LambDepartment of Biochemistry and Biophysics and Science for Life Laboratory, Stockholm University, Box 1031, Solna 17121, Sweden.
Matteo LambrughiComputational Biology Laboratory, Danish Cancer Society Research Center, Copenhagen DK-2100, Denmark.
Tamas LazarStructural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels 1050, Belgium.
Jeremy Y LeclercqCentre de Recherche en Biologie cellulaire de Montpellier (CRBM), UMR 5237 CNRS, Université Montpellier, Montpellier 34293, France.
Emanuela LeonardiDepartment of Woman and Child Health, University of Padova, Padova 35127, Italy.
Sandra Macedo-RibeiroInstituto de Biologia Molecular e Celular (IBMC) and Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto 4200-135, Portugal.
Mauricio Macossay-CastilloStructural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels 1050, Belgium.
Emiliano MaianiComputational Biology Laboratory, Danish Cancer Society Research Center, Copenhagen DK-2100, Denmark.
José A MansoInstituto de Biologia Molecular e Celular (IBMC) and Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto 4200-135, Portugal.
Cristina Marino-BusljeBioinformatics Unit. Fundación Instituto Leloir, Ciudad de Buenos Aires C1405BWE, Argentina.
Elizabeth Martínez-PérezBioinformatics Unit. Fundación Instituto Leloir, Ciudad de Buenos Aires C1405BWE, Argentina.
Bálint MészárosMTA-ELTE Lendület Bioinformatics Research Group, Department of Biochemistry, Eötvös Loránd University, Budapest 1117, Hungary.
Ivan MičetićDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.
Giovanni MinerviniDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.
Nikoletta MurvaiInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest H-1117, Hungary.
Marco NecciDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.
Christos A OuzounisBiological Computation & Process Laboratory, Chemical Process & Energy Resources Institute, Centre for Research & Technology Hellas, Thessalonica GR-57500, Greece.
Mátyás PajkosMTA-ELTE Lendület Bioinformatics Research Group, Department of Biochemistry, Eötvös Loránd University, Budapest 1117, Hungary.
Lisanna PaladinDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.
Rita PancsaInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest H-1117, Hungary.
Elena PapaleoComputational Biology Laboratory, Danish Cancer Society Research Center, Copenhagen DK-2100, Denmark.
Gustavo ParisiDepartamento de Ciencia y Tecnología, Universidad Nacional de Quilmes - CONICET, Bernal, Buenos Aires B1876BXD, Argentina.
Emilie PascheSwiss Institute of Bioinformatics and HES-SO \ HEG, Geneva 1200, Switzerland.
Pedro J Barbosa PereiraInstituto de Biologia Molecular e Celular (IBMC) and Instituto de Investigação e Inovação em Saúde (i3S), Universidade do Porto, Porto 4200-135, Portugal.
Vasilis J PromponasBioinformatics Research Laboratory, Department of Biological Sciences, University of Cyprus, Nicosia, CY 1678, Cyprus.
Jordi PujolsDepartament de Bioquímica i Biologia Molecular and Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Bellaterra 08193, Spain.
Federica QuagliaDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.
Patrick RuchSwiss Institute of Bioinformatics and HES-SO \ HEG, Geneva 1200, Switzerland.
Marco SalvatoreDepartment of Biochemistry and Biophysics and Science for Life Laboratory, Stockholm University, Box 1031, Solna 17121, Sweden.
Eva SchadInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest H-1117, Hungary.
Beata SzaboInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest H-1117, Hungary.
Tamás SzaniszlóMTA-ELTE Lendület Bioinformatics Research Group, Department of Biochemistry, Eötvös Loránd University, Budapest 1117, Hungary.
Stella TamanaBioinformatics Research Laboratory, Department of Biological Sciences, University of Cyprus, Nicosia, CY 1678, Cyprus.
Agnes TantosInstitute of Enzymology, Research Centre for Natural Sciences, Hungarian Academy of Sciences, Budapest H-1117, Hungary.
Nevena VeljkovicLaboratory for Bioinformatics and Computational Chemistry, Institute of Nuclear Sciences Vinca, University of Belgrade, Belgrade 11001, Serbia.
Salvador VenturaDepartament de Bioquímica i Biologia Molecular and Institut de Biotecnologia i Biomedicina, Universitat Autònoma de Barcelona, Bellaterra 08193, Spain.
Wim VrankenStructural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels 1050, Belgium.
Zsuzsanna DosztányiMTA-ELTE Lendület Bioinformatics Research Group, Department of Biochemistry, Eötvös Loránd University, Budapest 1117, Hungary.
Peter TompaStructural Biology Brussels, Vrije Universiteit Brussel (VUB), Brussels 1050, Belgium.
Silvio C E TosattoDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.
Damiano PiovesanDepartment of Biomedical Sciences, University of Padova, Padova 35121, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Database of Protein Disorder (DisProt, URL: https://disprot.org) provides manually curated annotations of intrinsically disordered proteins from the literature. Here we report recent developments with DisProt (version 8), including the doubling of protein entries, a new disorder ontology, improvements of the annotation format and a completely new website. The website includes a redesigned graphical interface, a better search engine, a clearer API for programmatic access and a new annotation interface that integrates text mining technologies. The new entry format provides a greater flexibility, simplifies maintenance and allows the capture of more information from the literature. The new disorder ontology has been formalized and made interoperable by adopting the OWL format, as well as its structure and term definitions have been improved. The new annotation interface has made the curation process faster and more effective. We recently showed that new DisProt annotations can be effectively used to train and validate disorder predictors. We believe the growth of DisProt will accelerate, contributing to the improvement of function and disorder predictors and therefore to illuminate the 'dark' proteome.

Indexed as

Databases, ProteinBiological OntologiesData CurationIntrinsically Disordered ProteinsMolecular Sequence AnnotationIntrinsically Disordered Proteins

Identifiers

PMID31713636
PMCPMC7145575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.